DNAJC5 and glioblastoma: CLN4 had amplification of EGFR, CDK8, and MIRH1. EGFR mutations in the extracellular domain with gene amplifications are common in glioblastomas [43] and mutations in the tyrosine kinase domain with increased copy numbers are seen in lung carcinomas.